Work Here?
Work Here?
Work Here?
Industries
Data & Analytics
Healthcare
Company Size
11-50
Company Stage
Early VC
Total Funding
$2.2M
Headquarters
Indianapolis, Indiana
Founded
2022
3Aware.ai focuses on post-market surveillance (PMS) of medical devices, helping manufacturers comply with regulations like the EU Medical Device Regulation (MDR). Their main product, aiSurveillance, is a real-time software platform that combines three separate solutions into one, allowing for efficient access, analysis, and alerts for real-world clinical data. By using artificial intelligence, the platform automates data collection and analysis, which helps reduce the time and costs associated with compliance for medical device manufacturers. Unlike competitors, 3Aware.ai offers a customizable, subscription-based service that adapts to the specific needs of each client, ensuring ongoing support and updates. The company's goal is to enhance the safety and effectiveness of medical devices while streamlining the regulatory process for manufacturers.
💡 Want to apply to 3Aware?
You have ways to get a 3Aware referral from your network.
Get referrals →
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$2.1M
Above
Industry Average
Funded Over
1 Rounds
Unlimited Paid Time Off
Remote Work Options
Flexible Work Hours
401(k) Company Match
Health Insurance
Vision Insurance
Dental Insurance
Life Insurance
Disability Insurance
Professional Development Budget
Stock Options
Wellness Program
INDIANAPOLIS, ID / ACCESSWIRE / July 30, 2024 / 3Aware, a leader in real-time surveillance and data solutions for medical technology, is pleased to announce the appointment of Prashant Thumma as its first Chief Technology Officer (CTO). Mr. Thumma brings a wealth of experience in technology leadership and innovation, poised to drive 3Aware's strategic growth.Thumma joins 3Aware with a distinguished career in health information technology. In his most recent role as Platform Architecture Senior Director at Teladoc Health, he led initiatives to enhance platform architecture and optimize operations. Previously, as Chief Architect and VP at Seven Bridges Genomics, he was instrumental in developing the company's multi-tenant bioinformatics platform and population analytics products. Mr
3Aware has filed a notice of an exempt offering of securities to raise $8,000,000.00 in New Equity Investment. 3Aware has filed a notice of an exempt offering of securities to raise $8,000,000.00 in New Equity Investment.According to filings with the U.S. Securities and Exchange Commission, 3Aware is raising up to $8,000,000.00 in new funding. Sources indicate that as part of senior management President, Chris Brown played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.About 3Aware3Aware supports immediate access to real-world clinical data for medical device manufacturers in a self-administered platform. MedTech Clinical and Regulatory teams spend exorbitant time and money on the real-world data collection to support keeping devices on the market. With a host of patchwork solutions, there remains no solution to meet their clinical data needs reliably, quickly and affordably
What You Should Know:– 3Aware, a provider of medical device regulatory compliance solutions, and Mayo Clinic Platform, a collaborative ecosystem for healthcare innovators, today announced a new partnership that will integrate 3Aware’s aiSurveillance solution with Mayo Clinic Platform’s extensive clinical data resources.– This collaboration marks a significant milestone in the industry as it will enable medical device manufacturers to automate post-market clinical follow-up (PMCF) and gain deeper insights into device safety and performance.Enhanced Device Coverage and Automated PMCFThe integration of aiSurveillance with Mayo Clinic Platform will significantly increase the device coverage of 3Aware’s solution, enabling manufacturers to automate PMCF for a broader range of devices. By leveraging Mayo Clinic Platform’s comprehensive, longitudinal real-world data, 3Aware will provide manufacturers with deeper insights into device-specific patient experience and outcomes.Reduced Cost, Time, and Risk of Regulatory Compliance3Aware’s aiSurveillance solution has been shown to reduce the cost, time, and risk of MedTech regulatory compliance. By using active surveillance, manufacturers can achieve PMCF-based compliance at less than 50% of the cost and one-tenth of the time of chart reviews and registries. Additionally, aiSurveillance provides a deeper, patient-level understanding with less bias compared to traditional methods.Access to Extensive Clinical DataMayo Clinic Platform provides unparalleled access to extensive, diverse, and de-identified clinical data, including structured data, such as demographics and diagnoses, and unstructured data, such as medical imaging and clinical notes. This data is continually updated and encompasses more than 3 billion images, 676 million clinical notes, 1.6 billion lab results, 9.7 million pathology reports, and 662 million clinical notes.Data Behind Glass: Secure Access to De-identified DataMayo Clinic Platform’s Data Behind Glass model enables secure access to extensive sets of de-identified data without moving it among the contributing organizations across multiple continents. This unique approach ensures patient privacy while providing manufacturers with the data they need to gain valuable insights into device safety and performance
INDIANAPOLIS, December 5, 2023 (Newswire.com). -. 3Aware, a pioneering force in the MedTech sector, is working with Mayo Clinic Platform, a collaborative ecosystem for healthcare innovators. This collaboration marks a significant milestone in the industry, as 3Aware integrates with Mayo Clinic Platform to enhance its arsenal of solutions that are redefining the landscape of regulatory compliance for medical device manufacturers
INDIANAPOLIS, June 20, 2023 (Newswire.com). -. 3Aware today announced the release of 3Aware aiSurveillance, a new approach to real-time medical device surveillance for post-market clinical follow-up (PMCF). This first-of-its-kind solution enables MedTech manufacturers to achieve PMCF and surveillance compliance at 25% of the cost and 1/10 of the time of current methods.
Find jobs on Simplify and start your career today
Discover companies similar to 3Aware
Industries
Data & Analytics
Healthcare
Company Size
11-50
Company Stage
Early VC
Total Funding
$2.2M
Headquarters
Indianapolis, Indiana
Founded
2022
Find jobs on Simplify and start your career today
Discover companies similar to 3Aware